It takes approx. seven years to diagnose a patient with a rare disease. It doesn’t have to be this way. We are excited to share that our enhanced Whole Exome Sequencing (WES) solution is now out! All WES samples received by our lab starting 1st June will be on this new enhanced CentoXome®. We are Read More
Join Genomind’s Medical Science Liaisons, Dr. Russell Amato and Dr. Tori Hoffman, as they present on the management of generalized anxiety disorder. They will discuss various treatment options and associated evidence, as well as highlight pharmacogenetic considerations in the management of this challenging clinical presentation.
Genomind and guest speaker, Dr. Jeffrey R. Strawn, MD, FAACP, present Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents. Dr. Strawn, an Associate Professor of the Department of Pediatrics at the University of Cincinnati, is a psychiatrist specializing in the neurophysiology, neurochemistry and neuroanatomy of anxiety Read More
Throughout the CentoTalk, Clarice Loh provides a detailed overview of CENTOGENE’s prenatal screening options and how prenatal testing plays an essential role in facilitating early answers when they’re needed most. Key Topics: Clinical Indication and Genetic Testing in Prenatal Cases CentoScreen®, CentoNIPT®, Microarray Testing CentoXome® (WES) & CentoGenome® (WGS) Repeat Expansion Diseases
We understand there is a lot of misinformation and confusion about genetic testing and prostate cancer. Understanding your DNA through genetic testing can illuminate your health, qualify you for new treatments, and give loved ones peace of mind. To simplify matters, we have put together a list of the top four reasons why men with Read More